Training and resources for safe research with dangerous pathogens
Official title: BSL-3 Practices Core
Funded at University of Missouri-Columbia · NIH-10910192 · Data updated 2026-11-12
This study is all about helping researchers who work with dangerous germs, like the coronavirus, by giving them the training and tools they need to stay safe while they study these diseases, so they can find better ways to understand and treat infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $718,778 |
| NIH project number | 5UC7AI180306-02 |
| Project ID | NIH-10910192 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include researchers and laboratory personnel who work with BSL-3 pathogens.
✕Less likely to help
Patients who are not involved in research or laboratory work with infectious diseases may not receive direct benefits from this research.
What this research studies
This research focuses on providing essential training and resources for researchers working with Biosafety Level 3 (BSL-3) pathogens, such as the novel coronavirus. It includes components like biosafety planning, user training, and oversight of compliance with safety regulations. The goal is to ensure that researchers are well-prepared to handle these pathogens safely and effectively, thereby supporting ongoing research efforts in infectious diseases. By enhancing safety protocols and training, the project aims to facilitate critical research that can lead to better understanding and management of infectious diseases.
Why it matters
Potential benefit: If successful, this research could enhance the safety and effectiveness of research involving dangerous pathogens, ultimately contributing to better public health outcomes.
How similar studies have gone: Other research initiatives focusing on biosafety training and compliance have shown success in improving laboratory safety and research outcomes.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Adamovicz, Jeffrey Joseph — University of Missouri-Columbia
- Study coordinator: Adamovicz, Jeffrey Joseph
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
Interface between immune cells and scarring in the eye
This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.
-
Understanding cell-cleanup problems in C9ORF72-related ALS/FTD
Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.
-
Molecular clues to endometriosis-related infertility
This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.
-
A universal Shigella vaccine using SAVE to protect people of all ages
A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.
-
Biomarkers that predict osteoarthritis risk in people at higher risk
A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.